Registry for heart transplant outcomes using OCS Heart System

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The US National OCS Heart Perfusion Registry is an observational registry aimed at collecting data on the clinical outcomes of heart transplant recipients who receive donor hearts preserved with the OCS Heart System. This multi-center initiative will follow patients for up to five years post-transplant to assess the performance of the OCS Heart device in real-world settings after its FDA approval. The registry will provide valuable insights into the effectiveness and safety of this preservation method in heart transplantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* N/A

Exclusion Criteria:

* N/A

Where it's running

• Banner University Medical Center Phoenix
  Phoenix, Arizona, United States Recruiting
• University of California San Diego
  La Jolla, California, United States Recruiting
• Lucile Packard Children's Hospital Stanford
  Palo Alto, California, United States Recruiting
• Stanford University
  Palo Alto, California, United States Recruiting
• University of California San Francisco
  San Francisco, California, United States Recruiting
• Boulder
  Boulder, Colorado, United States Recruiting

Study contacts

• Study coordinator: Raicca Haqqi
• Email: rhaqqi@transmedics.com
• Phone: 9788090620

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-invasive test to predict early heart rejection in pediatric transplant patients

  This study tests non-invasive heart tests like cardiac MRI and blood markers to see if they can detect rejection in kids after heart transplant, potentially reducing the need for invasive biopsies.

  Recruiting at 22 sites Vanderbilt University Medical Center · Little Rock, Arkansas and 21 other locations · NCT07770659

• Non-intubated anesthesia for adult heart transplantation

  This trial tests whether keeping patients breathing on their own with a supraglottic airway during heart transplantation leads to fewer complications and faster recovery compared with standard intubated anesthesia.

  Recruiting The First Affiliated Hospital of Guangzhou Medical University · Guangzhou, Guangdong · NCT07758894

• Apixaban vs Warfarin in HeartMate 3 LVAD Patients

  This study tests whether apixaban can replace warfarin to prevent clots and bleeding problems in adults with an implanted HeartMate 3 LVAD for at least 3 months.

  Recruiting Phase 3 Columbia University · New York, New York · NCT07471139

• Improving donor heart preservation with the OCS Heart System

  This study will test whether the OCS Heart System with a new preservation solution and a functional enhancer helps donor hearts—including DCD and higher‑risk DBD hearts—stay healthier and improve transplant outcomes compared with standard cold storage.

  Recruiting at 7 sites TransMedics · San Francisco, California and 7 other locations · NCT07145515

• XVIVO Heart Box non-ischemic preservation for transporting donor hearts.

  This program tests whether the XVIVO non-ischemic heart preservation system can safely preserve extended-criteria donor hearts for adults waiting for a heart transplant.

  Recruiting at 14 sites XVIVO Perfusion · La Jolla, California and 13 other locations · NCT06895070

• Empagliflozin to protect kidney and heart health after heart transplant

  This trial will test whether empagliflozin can protect kidney and heart health and improve metabolic and functional outcomes in Veterans who have had a heart transplant.

  Recruiting Phase 4 VA Office of Research and Development · Palo Alto, California and 5 other locations · NCT06625073

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.